Skip to content 
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy dispensing services; IV compounding services; turnkey solution designed to help health systems establish, manage, and optimize an entity-owned specialty pharmacy, as well as support onsite management of specialty pharmacy services, including payer contracting, staffing, licensing, and 340B program administration. In addition, the company offers inventory optimization services comprising predictive and prescriptive analytics, benchmarking, workflow tools, and clinical resources, as well as medication inventory visibility; patient engagement, clinical, and financial solutions; medication adherence solutions, which include single-dose automation solutions, automated and semi-automated filling equipment, various medication blister card packaging and packaging supplies; and software that guides users through the manual filling process. Further, it provides professional services, such as technology installation, program management, customer education and training, change management services, and related offerings; technical services comprising post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; and retail pharmacy and hospital automation outside the United States business. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. The company was incorporated in 1992 and is headquartered in Fort Worth, Texas. more
| Time Frame | OMCL | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -19% | 0.14% | 0.86% |
| 1-Month Return | -26.12% | -0.72% | -0.47% |
| 3-Month Return | 1.91% | 3.7% | 1.34% |
| 6-Month Return | 22.67% | 19.92% | 8.86% |
| 1-Year Return | -8.32% | 7% | 14.32% |
| 3-Year Return | -30.21% | 16.96% | 67.75% |
| 5-Year Return | -71.38% | 34.22% | 77.15% |
| 10-Year Return | 41.07% | 145.99% | 279.46% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 1.13B | 1.30B | 1.15B | 1.11B | 1.18B | [{"date":"2021-12-31","value":87.35,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":88.52,"profit":true},{"date":"2024-12-31","value":85.82,"profit":true},{"date":"2025-12-31","value":91.43,"profit":true}] |
| Cost of Revenue | 577.37M | 706.96M | 650.27M | 641.24M | 681.40M | [{"date":"2021-12-31","value":81.67,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.98,"profit":true},{"date":"2024-12-31","value":90.7,"profit":true},{"date":"2025-12-31","value":96.38,"profit":true}] |
| Gross Profit | 554.65M | 588.99M | 496.84M | 471.00M | 503.44M | [{"date":"2021-12-31","value":94.17,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":84.36,"profit":true},{"date":"2024-12-31","value":79.97,"profit":true},{"date":"2025-12-31","value":85.48,"profit":true}] |
| Gross Margin | 49.00% | 45.45% | 43.31% | 42.35% | 42.49% | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":92.76,"profit":true},{"date":"2023-12-31","value":88.4,"profit":true},{"date":"2024-12-31","value":86.43,"profit":true},{"date":"2025-12-31","value":86.72,"profit":true}] |
| Operating Expenses | 465.15M | 591.31M | 531.71M | 470.67M | 498.28M | [{"date":"2021-12-31","value":78.66,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":89.92,"profit":true},{"date":"2024-12-31","value":79.6,"profit":true},{"date":"2025-12-31","value":84.27,"profit":true}] |
| Operating Income | 89.51M | (2.32M) | (34.87M) | 337.00K | 5.16M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-2.6,"profit":false},{"date":"2023-12-31","value":-38.96,"profit":false},{"date":"2024-12-31","value":0.38,"profit":true},{"date":"2025-12-31","value":5.76,"profit":true}] |
| Total Non-Operating Income/Expense | (47.00M) | (260.00K) | 27.52M | 50.51M | - | [{"date":"2021-12-31","value":-93.05,"profit":false},{"date":"2022-12-31","value":-0.51,"profit":false},{"date":"2023-12-31","value":54.47,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Pre-Tax Income | 66.01M | (2.45M) | (20.11M) | 25.59M | 11.32M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-3.72,"profit":false},{"date":"2023-12-31","value":-30.46,"profit":false},{"date":"2024-12-31","value":38.77,"profit":true},{"date":"2025-12-31","value":17.16,"profit":true}] |
| Income Taxes | (11.84M) | (8.10M) | 263.00K | 13.06M | 9.27M | [{"date":"2021-12-31","value":-90.66,"profit":false},{"date":"2022-12-31","value":-62.02,"profit":false},{"date":"2023-12-31","value":2.01,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":70.99,"profit":true}] |
| Income After Taxes | 77.85M | 5.65M | (20.37M) | 12.53M | - | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":7.26,"profit":true},{"date":"2023-12-31","value":-26.17,"profit":false},{"date":"2024-12-31","value":16.1,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Continuous Operations | 77.85M | 5.65M | (34.40M) | 12.53M | - | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":7.26,"profit":true},{"date":"2023-12-31","value":-44.19,"profit":false},{"date":"2024-12-31","value":16.1,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | 77.85M | 5.65M | (20.37M) | 12.53M | 2.05M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":7.26,"profit":true},{"date":"2023-12-31","value":-26.17,"profit":false},{"date":"2024-12-31","value":16.1,"profit":true},{"date":"2025-12-31","value":2.64,"profit":true}] |
| EPS (Diluted) | 3.80 | 3.00 | 1.91 | 1.70 | 1.62 | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":78.95,"profit":true},{"date":"2023-12-31","value":50.26,"profit":true},{"date":"2024-12-31","value":44.74,"profit":true},{"date":"2025-12-31","value":42.63,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| OMCL | |
|---|---|
| Cash Ratio | 0.41 |
| Current Ratio | 1.43 |
| Quick Ratio | 1.22 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| OMCL | |
|---|---|
| ROA (LTM) | 0.30% |
| ROE (LTM) | 0.17% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| OMCL | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.38 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.62 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| OMCL | |
|---|---|
| Trailing PE | 975.00 |
| Forward PE | 29.50 |
| P/S (TTM) | 1.51 |
| P/B | 1.42 |
| Price/FCF | 89 |
| EV/R | 1.47 |
| EV/Ebitda | 19.02 |
| PEG | 2.28 |
Omnicell Inc (OMCL) share price today is $37.36
Yes, Indians can buy shares of Omnicell Inc (OMCL) on Vested. To buy
Yes, you can purchase fractional shares of Omnicell Inc (OMCL) via the Vested app. You can start investing in Omnicell Inc (OMCL) with a minimum investment of $1.
You can invest in shares of Omnicell Inc (OMCL) via Vested in three simple steps:
The 52-week high price of Omnicell Inc (OMCL) is $55. The 52-week low price of Omnicell Inc (OMCL) is $22.66.
The price-to-earnings (P/E) ratio of Omnicell Inc (OMCL) is 975
The price-to-book (P/B) ratio of Omnicell Inc (OMCL) is 1.42
The dividend yield of Omnicell Inc (OMCL) is 0.00%
The market capitalization of Omnicell Inc (OMCL) is $1.70B
The stock symbol (or ticker) of Omnicell Inc is OMCL
Consider the share price of Omnicell Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Omnicell Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Omnicell Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Omnicell Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Omnicell Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Omnicell Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
